Platelets at the interface of thrombosis, inflammation, and cancer.
about
The Elastin Receptor Complex: A Unique Matricellular Receptor with High Anti-tumoral PotentialPlatelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapiesIn Vitro Mode of Action and Anti-thrombotic Activity of Boophilin, a Multifunctional Kunitz Protease Inhibitor from the Midgut of a Tick Vector of Babesiosis, Rhipicephalus microplusData detailing the platelet acetyl-lysine proteomePlatelet protective efficacy of 3,4,5 trisubstituted isoxazole analogue by inhibiting ROS-mediated apoptosis and platelet aggregation.[Thrombocytopenia in the intensive care unit : Diagnosis, differential diagnosis, and treatment].Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.Measurement of platelet aggregation, independently of patient platelet count: a flow-cytometric approach.Towards the Manufacture of Megakaryocytes and Platelets for Clinical Application.Preparation of Platelet Concentrates for Research and Transfusion Purposes.Increased platelet distribution width predicts poor prognosis in melanoma patientsPreoperative platelet to lymphocyte and neutrophil to lymphocyte ratios are independent prognostic factors for patients undergoing lung cancer radical surgery: A single institutional cohort study.Prognostic value of preoperative plasma fibrinogen level and platelet-to-lymphocyte ratio (F-PLR) in patients with localized upper tract urothelial carcinoma.Lack of association between platelet indices and disease stage in osteosarcoma at diagnosisWhite blood cell and platelet indices as prognostic markers in patients with invasive ductal breast carcinoma.mTORC1 promotes aging-related venous thrombosis in mice via elevation of platelet volume and activation.The preoperative alkaline phosphatase-to-platelet ratio index is an independent prognostic factor for hepatocellular carcinoma after hepatic resection.Blood-based omic profiling supports female susceptibility to tobacco smoke-induced cardiovascular diseases.Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma.Causes of variation in the neutrophil-lymphocyte and platelet-lymphocyte ratios: a twin-family study.Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survival.Pathogenic role of platelets in rheumatoid arthritis and systemic autoimmune diseases. Perspectives and therapeutic aspects.Lipid profile of platelets and platelet-derived microparticles in ovarian cancer.Platelets in neutrophil recruitment to sites of inflammation.Emerging Biological Principles of Metastasis.Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting.Implementing liquid biopsies into clinical decision making for cancer immunotherapy.Platelet "first responders" in wound response, cancer, and metastasis.DNA methylation signatures and coagulation factors in the peripheral blood leucocytes of epithelial ovarian cancer.Lower mean platelet volume predicts poor prognosis in renal cell carcinoma.Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?Mean Platelet Volume and Immature Platelet Fraction in Autoimmune Disorders.A physical description of the adhesion and aggregation of platelets.Heparanase expression upregulates platelet adhesion activity and thrombogenicity.Label free monitoring of megakaryocytic development and proplatelet formation in vitro.Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer.A conduit to metastasis: circulating tumor cell biology.The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer.MAPK, NFκB, and VEGF signaling pathways regulate breast cancer liver metastasis.Association between multimorbidity and mean platelet volume in diabetic patients with acute myocardial infarction.
P2860
Q26765998-C1BCCCC7-8A2B-4A4A-BA97-77CDAC707A93Q28068448-3B80A149-5326-4DEB-9DF3-EFFBD8622E14Q28552239-15EF1D63-C1DD-46AB-A320-E8C4612CE914Q31048423-223593DB-A6F4-4B91-97AB-4D8AB6DCF6DAQ33430161-CBACEFE3-28C2-4FE2-96EE-A069C4E51640Q33432680-85AF4429-ABE9-4E25-86D4-315B3C22D410Q33432917-33D98C63-9E52-4B89-919F-DFDDAC5B5F73Q33440160-29ED2148-719D-4C87-ABDD-5435A44B2CB7Q33442786-6A9507A3-142D-42DA-8115-0504782B0A9DQ33443256-4A8A62BE-ACE0-44CF-8229-C6038C4CE454Q33774185-46212F43-90E4-4E6B-B656-DEE0F2516FC0Q33798830-59D83D4F-54EF-47D3-A149-D4DB860F4627Q33829643-71838BF8-B961-455F-BA3C-9157D1082607Q36337925-6C27EE31-9501-42B7-BB43-8F508EAAA2F6Q37107759-F4C0FFA6-4600-4C1A-94D3-0844469D82A8Q37396328-26DB80A8-5823-48FB-A0F3-E6AAFEB9F456Q37530615-75CEF58E-52E0-48A1-A789-F626B226DBD7Q37657771-E738B148-DBA8-4710-8DDE-492D99CFF9EDQ37745835-7476CDEC-EE78-4810-A308-AA893EF8E68BQ38377017-9CB971E9-6BBF-421D-8FE9-71BB579A5B48Q38620295-77E45E9E-33F9-4F8E-A2A0-E6668F06CDB6Q38799905-75717AB7-5D45-4591-9F9F-1943F952B922Q38838277-09D1A407-1622-477A-93FD-FD07CC7FEC72Q39001947-02AF1D74-F427-436C-B5CE-B6DE32B4360DQ39130446-ACF61186-8333-4D57-9149-F9410B6AFC58Q39294808-EAEBAB17-CBC1-4BC6-A78A-AF253521091AQ39304648-761592F7-C789-410C-B752-CC7826055BCBQ39449769-02E6CECC-0E22-4236-A302-8B82F1F44D11Q40150881-3219FD1C-2230-4078-AF78-C67E4F352BC1Q41159136-924176C1-69E9-49E0-8DC7-CA74E550534EQ41420993-2B35BC1C-628C-4A5A-96E8-B96C9ED2ED41Q41440643-357C0087-F318-4C91-A08C-60E63A58D8CBQ42289828-F1A2E71F-CDA3-4201-BD97-6E26091D4764Q42361194-C0799EE0-9BE1-4B32-A491-B166FEACAB54Q42639464-11C9FE64-B4E4-4CAE-AA18-2873C6FE5CA8Q46002939-D2A34562-6A65-4F33-B6BD-ABCD656325D2Q46280012-8CD32D38-5781-4FE7-A435-C06212EED2EEQ47136332-628181D0-DF58-49A1-AECC-B82BFF0DE0E5Q47160810-A71D3755-7CB4-4562-8FDD-EC1BE17591C5Q47391905-2CDF43C1-99C7-41C7-9EC0-4D3507549374
P2860
Platelets at the interface of thrombosis, inflammation, and cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Platelets at the interface of thrombosis, inflammation, and cancer.
@ast
Platelets at the interface of thrombosis, inflammation, and cancer.
@en
type
label
Platelets at the interface of thrombosis, inflammation, and cancer.
@ast
Platelets at the interface of thrombosis, inflammation, and cancer.
@en
prefLabel
Platelets at the interface of thrombosis, inflammation, and cancer.
@ast
Platelets at the interface of thrombosis, inflammation, and cancer.
@en
P2860
P1433
P1476
Platelets at the interface of thrombosis, inflammation, and cancer
@en
P2093
Adam Corken
P2860
P304
P356
10.1182/BLOOD-2014-08-531582
P407
P577
2015-06-24T00:00:00Z